JP2024519614A5 - - Google Patents

Info

Publication number
JP2024519614A5
JP2024519614A5 JP2023568236A JP2023568236A JP2024519614A5 JP 2024519614 A5 JP2024519614 A5 JP 2024519614A5 JP 2023568236 A JP2023568236 A JP 2023568236A JP 2023568236 A JP2023568236 A JP 2023568236A JP 2024519614 A5 JP2024519614 A5 JP 2024519614A5
Authority
JP
Japan
Prior art keywords
seq
amino acid
acid sequence
nucleic acid
cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023568236A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024519614A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2022/062338 external-priority patent/WO2022234116A1/en
Publication of JP2024519614A publication Critical patent/JP2024519614A/ja
Publication of JP2024519614A5 publication Critical patent/JP2024519614A5/ja
Pending legal-status Critical Current

Links

JP2023568236A 2021-05-07 2022-05-06 Prame特異的t細胞受容体とキメラ補助刺激受容体との組合せ Pending JP2024519614A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP21172722 2021-05-07
EP21172722.7 2021-05-07
PCT/EP2022/062338 WO2022234116A1 (en) 2021-05-07 2022-05-06 Combination of prame specific t cell receptors and chimeric co-stimulatory receptors

Publications (2)

Publication Number Publication Date
JP2024519614A JP2024519614A (ja) 2024-05-20
JP2024519614A5 true JP2024519614A5 (https=) 2025-05-14

Family

ID=75870458

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023568236A Pending JP2024519614A (ja) 2021-05-07 2022-05-06 Prame特異的t細胞受容体とキメラ補助刺激受容体との組合せ

Country Status (8)

Country Link
US (1) US20240277762A1 (https=)
EP (1) EP4334331A1 (https=)
JP (1) JP2024519614A (https=)
KR (1) KR20240005865A (https=)
CN (1) CN117279931A (https=)
AU (1) AU2022270947A1 (https=)
CA (1) CA3215758A1 (https=)
WO (1) WO2022234116A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024146951A1 (en) * 2023-01-06 2024-07-11 Immunocore Limited Binding molecules against a prame peptide-hla complex
WO2025219541A1 (en) * 2024-04-19 2025-10-23 Medigene Immunotherapies Gmbh Constant uni-tabs
EP4635976A1 (en) * 2024-04-19 2025-10-22 Medigene Immunotherapies GmbH Constant uni-tabs

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4703004A (en) 1984-01-24 1987-10-27 Immunex Corporation Synthesis of protein with an identification peptide
US4851341A (en) 1986-12-19 1989-07-25 Immunex Corporation Immunoaffinity purification system
EP2006376A1 (en) 2007-06-21 2008-12-24 Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt GmbH Fusion protein comprising a caspase domain and a nuclear hormone receptor binding domain and methods and uses thereof
CA2978171A1 (en) * 2015-03-10 2016-09-15 J.H. Frederik Falkenburg T-cell receptors directed against the preferentially expressed antigen of melanoma and uses thereof
KR102436129B1 (ko) * 2016-06-17 2022-08-26 메디진 이뮤노테라피스 게엠바하 T 세포 수용체 및 이의 용도
AU2017382243A1 (en) * 2016-12-22 2019-05-02 Windmil Therapeutics, Inc. Compositions and methods for modulating the immune system
GB201709866D0 (en) * 2017-06-20 2017-08-02 Immunocore Ltd T cell receptors
US11738047B2 (en) * 2017-12-12 2023-08-29 The Trustees Of The University Of Pennsylvania Genetically modified immune cells targeting NY-ESO-1 and methods of use thereof
EP3731876A4 (en) * 2017-12-28 2022-04-06 Gritstone bio, Inc. ANTIGEN-BINDING PROTEINS TARGETING SHARED ANTIGENS
US20220401484A1 (en) * 2019-11-18 2022-12-22 BioNTech SE Prame TCR Receptors And Uses Thereof

Similar Documents

Publication Publication Date Title
JP2024519614A5 (https=)
JP2022502056A5 (https=)
JP2023139070A5 (https=)
AU2017371260C1 (en) T cell receptors with improved pairing
ES2904301T3 (es) Receptores de células T dirigidos contra Bob1 y usos de los mismos
ES2912743T3 (es) Receptores de linfocitos T
JP2021522790A5 (https=)
JP2021520198A5 (https=)
JP2025060882A5 (https=)
JP2017537627A5 (https=)
JP7288503B2 (ja) 改変された抗cd19 car-t細胞
JP2018531014A5 (https=)
JP2019536437A5 (https=)
JP2016520074A5 (https=)
EP4243857A1 (en) Combination therapies with chimeric antigen receptor (car)-expressing cells
JP2021526795A5 (https=)
JP2019513394A5 (https=)
JP2016538855A5 (https=)
JP2021531834A5 (https=)
JP2024540275A5 (https=)
JP2023539591A5 (https=)
JP2022533092A5 (https=)
JP2022521240A5 (https=)
JP7570640B2 (ja) Cd22特異的なt細胞受容体およびb細胞悪性腫瘍の処置のための養子t細胞療法
JP2021505190A5 (https=)